Adlai Nortye Ltd. (NASDAQ:ANL – Get Free Report) was the recipient of a large increase in short interest in the month of June. As of June 15th, there was short interest totalling 13,000 shares, an increase of 21.5% from the May 31st total of 10,700 shares. Based on an average daily volume of 16,500 shares, the days-to-cover ratio is presently 0.8 days.
Adlai Nortye Price Performance
NASDAQ:ANL traded down $0.45 during mid-day trading on Friday, hitting $3.26. 2,493 shares of the company’s stock traded hands, compared to its average volume of 21,373. The firm has a 50 day moving average of $9.05 and a two-hundred day moving average of $8.97. Adlai Nortye has a 12 month low of $3.04 and a 12 month high of $19.30.
Institutional Trading of Adlai Nortye
A hedge fund recently raised its stake in Adlai Nortye stock. Cantor Fitzgerald L. P. lifted its stake in Adlai Nortye Ltd. (NASDAQ:ANL – Free Report) by 128.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 40,310 shares of the company’s stock after buying an additional 22,644 shares during the period. Cantor Fitzgerald L. P. owned about 0.11% of Adlai Nortye worth $362,000 at the end of the most recent reporting period. 35.21% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on Adlai Nortye
About Adlai Nortye
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas.
Further Reading
- Five stocks we like better than Adlai Nortye
- What Are Trending Stocks? Trending Stocks Explained
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- The Most Important Warren Buffett Stock for Investors: His Own
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Health Care Stocks Explained: Why You Might Want to Invest
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for Adlai Nortye Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye and related companies with MarketBeat.com's FREE daily email newsletter.